Today’s Research Reports on Trending Tickers: InspireMD and Eli Lilly and Company

NEW YORK, NY / ACCESSWIRE / February 23, 2018 / U.S. equities recovered on Thursday with the Dow Jones and S&P 500 closing in the green. The Federal Reserve released minutes from their Wednesday meeting that suggested a higher possibility of an interest rate hike. The Dow Jones Industrial Average settled to close at 24,962.48, up by 0.66 percent, while the S&P 500 Index gained 0.10 percent to close at 2,703.96. The Nasdaq Composite Index fell 0.11 percent to close at 7,210.09.

“We’re seeing a repricing of risk, given the anticipation of inflation and higher rates, but some of that is a byproduct of an improving economy, one that’s growing faster than normal. In general, the broader economic conditions continue to improve,” said Steven Baffico, chief executive officer at Four Wood Capital Partners.

RDI Initiates Coverage on:

InspireMD, Inc.
https://rdinvesting.com/news/?ticker=NSPR

Eli Lilly and Company
https://rdinvesting.com/news/?ticker=LLY

InspireMD’s stock moved 2.38% lower Thursday, to close the day at $4.10. The stock declined despite the company’s announcement that it has signed an exclusive distribution, sales and marketing agreement with Solvit Medical Inc. (“Solvit”), a leading distributor of medical devices and pharmaceuticals in South Korea. The stock recorded a trading volume of 1,585,770 shares, which was below its three months average volume of 10,421,918 shares. In the last year, InspireMD’s shares have traded in a range of 0.12 – 7.80. The share price has gained 3,316.67% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $1.44 is greater than its 200-day moving average of $0.61. Shares of InspireMD have fallen roughly 41.43 percent in the past month and are down 8.77 percent year-to-date.

Access RDI’s InspireMD, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NSPR

On Thursday, shares of Eli Lilly and Company recorded a trading volume of 7,687,429 shares, which was above the three months average volume of 4,400,340 shares. The stock ended the day 0.46% lower at 77.19. The stock is currently trading 13.36% below its 52-week high with a 52-week trading range of 73.69 – 89.09. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $82.38 is below its 200-day moving average of $83.36. Shares of Eli Lilly and Company have fallen roughly 9.66 percent in the past month and are down 8.61 percent year-to-date.

Access RDI’s Eli Lilly and Company Research Report at:
https://rdinvesting.com/news/?ticker=LLY

Our Actionable Research on InspireMD, Inc. (NYSE:NSPR) and Eli Lilly and Company (NYSE:LLY) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 490513